Michael Greenhalgh Sells 1,088 Shares of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Stock

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) COO Michael Greenhalgh sold 1,088 shares of Tabula Rasa HealthCare stock in a transaction that occurred on Wednesday, January 12th. The stock was sold at an average price of $15.69, for a total transaction of $17,070.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Michael Greenhalgh also recently made the following trade(s):

  • On Monday, January 3rd, Michael Greenhalgh sold 1,100 shares of Tabula Rasa HealthCare stock. The shares were sold at an average price of $15.67, for a total transaction of $17,237.00.

TRHC stock opened at $15.02 on Friday. Tabula Rasa HealthCare, Inc. has a one year low of $10.05 and a one year high of $69.31. The company’s fifty day moving average price is $13.45 and its 200-day moving average price is $27.21. The company has a debt-to-equity ratio of 5.15, a quick ratio of 1.27 and a current ratio of 1.35. The company has a market capitalization of $386.30 million, a PE ratio of -3.90 and a beta of 1.05.

Tabula Rasa HealthCare (NASDAQ:TRHC) last released its earnings results on Thursday, November 4th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.19) by $0.15. Tabula Rasa HealthCare had a negative net margin of 27.37% and a negative return on equity of 44.56%. The firm had revenue of $86.60 million for the quarter, compared to the consensus estimate of $88.54 million. During the same quarter in the previous year, the firm earned ($0.35) earnings per share. The company’s quarterly revenue was up 22.8% compared to the same quarter last year. On average, research analysts predict that Tabula Rasa HealthCare, Inc. will post -1.75 EPS for the current fiscal year.

Institutional investors have recently added to or reduced their stakes in the stock. Millennium Management LLC raised its stake in Tabula Rasa HealthCare by 217.6% during the second quarter. Millennium Management LLC now owns 121,121 shares of the company’s stock valued at $6,056,000 after purchasing an additional 82,983 shares in the last quarter. Vontobel Holding Ltd. raised its stake in Tabula Rasa HealthCare by 50.3% during the third quarter. Vontobel Holding Ltd. now owns 81,927 shares of the company’s stock valued at $2,148,000 after purchasing an additional 27,405 shares in the last quarter. Nisa Investment Advisors LLC purchased a new stake in Tabula Rasa HealthCare during the second quarter valued at $85,000. Millrace Asset Group Inc. bought a new position in Tabula Rasa HealthCare during the second quarter valued at $2,674,000. Finally, Grandeur Peak Global Advisors LLC increased its position in Tabula Rasa HealthCare by 134.7% during the second quarter. Grandeur Peak Global Advisors LLC now owns 22,698 shares of the company’s stock valued at $1,135,000 after acquiring an additional 13,025 shares during the last quarter. 85.31% of the stock is currently owned by institutional investors.

Several analysts recently issued reports on the stock. Royal Bank of Canada cut their target price on shares of Tabula Rasa HealthCare from $70.00 to $23.00 and set an “outperform” rating for the company in a research report on Monday, November 8th. Benchmark cut their target price on shares of Tabula Rasa HealthCare from $55.00 to $30.00 and set a “buy” rating for the company in a research report on Tuesday, November 9th. Piper Sandler cut their target price on shares of Tabula Rasa HealthCare from $41.00 to $13.00 and set a “neutral” rating for the company in a research report on Friday, November 5th. Zacks Investment Research upgraded shares of Tabula Rasa HealthCare from a “sell” rating to a “hold” rating and set a $17.00 target price for the company in a research report on Friday, January 7th. Finally, Stifel Nicolaus dropped their price target on shares of Tabula Rasa HealthCare from $42.00 to $24.00 and set a “hold” rating for the company in a research report on Friday, November 5th. Seven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $27.80.

About Tabula Rasa HealthCare

Tabula Rasa Healthcare, Inc is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services.

Recommended Story: Cost of Goods Sold (COGS)

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.